{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Frederick",
      "advisory_committee_description": "Pathology",
      "address_1": "7335 Executive Way",
      "address_2": "",
      "statement_or_summary": "Summary",
      "product_code": "SBY",
      "openfda": {
        "registration_number": [
          "3011805506"
        ],
        "fei_number": [
          "3011805506"
        ],
        "device_name": "High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids",
        "medical_specialty_description": "Pathology",
        "regulation_number": "866.6085",
        "device_class": "2"
      },
      "zip_code": "21704",
      "applicant": "Life Technologies Corporation",
      "decision_date": "2026-10-15",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "Oncomine ™ Dx Express Test",
      "advisory_committee": "PA",
      "contact": "Ángel  Casanova-Torres",
      "expedited_review_flag": "",
      "k_number": "K260827",
      "state": "MD",
      "date_received": "2026-03-13",
      "review_advisory_committee": "PA",
      "postal_code": "21704",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}